iBio, Inc. Common Stock (IBIO) is a publicly traded Healthcare sector company. As of September 17, 2026, IBIO trades at $1.22 with a market cap of $76.53M and a P/E ratio of -3.67. IBIO moved +2.97% today. Year to date, IBIO is -38.86%; over the trailing twelve months it is +36.53%. Its 52-week range spans $0.56 to $6.89. Analyst consensus is strong buy with an average price target of $5.33. Rallies surfaces IBIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks IBIO insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $1.22 |
| Market Cap | $76.53M |
| P/E Ratio | -3.67 |
| EPS | $-0.32 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.89 |
| 52-Week Low | $0.56 |
| Volume | 15.58K |
| Avg Volume | 0 |
| Revenue (TTM) | $100.00K |
| Net Income | $-33.04M |
| Gross Margin | 0.00% |
3 analysts cover IBIO: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $5.33.